1Shigeto E. Survey of anti-tuberculosis drug-induced severe liver injury in Japan[J]. Kekkaku, 2007,82 (5) : 467-473.
2Hsu MS,Wang JL, Ko WJ, et al. Clinical features and outcome of tuberculosis in solid organ transplant recipients[J]. Am J Med Sci,2007,334(2) : 106-110.
3Aguado JM, Herrero JA, Gavalda J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA [J]. Transplantation, 1997, 63 ( 9 ) : 1278-1286.
5Saukkonen JJ, Cohn DI., Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy[J]. Am J Respir Crit Care Med,2006, t74(8) :935-952.
5W Lu, CT Wai, M Da Costa, et al. Tuberculosis Post-Liver Transplantation:A Rare but Complicated DISEASE[J]. An nals Academy of Medicine, 2005,34 (2) : 213-215.
6Wang B, Lu, Y, Yu L, et al. Diagnosis and treatment for tuberculosis infection in liver transplant recipients: case reports [J]. Transplantation proceedings, 2007,39 : 3509-3511.
7Barcena R, Oton E, Angeles M, et al. Is liver transplanta tion advisable for isoniazid fulminant hepatitis in active ex trapulmonary tuberculosis[J]. American Journal of trans plantation, 2005,5: 2796-2798.
8Nagai S, Fujimoto Y, Taira K, et al. Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis[J]. Clinical Transplantation,2007,21 : 229-234.
